Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.

Psychotherapy addresses fear and anxiety that can blunt hormone and pelvic floor therapy in menopause care, according to Sheryl Kingsberg, PhD.

Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.

HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.

Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.